share_log

醫渡科技:致非登記持有人通知信函及申請表格

YIDU TECH: Notification Letter and Request Form to Non-registered Holders

香港交易所 ·  Dec 28, 2023 03:34
Summary by Moomoo AI
醫渡科技有限公司(「本公司」)已於2023年12月29日向非登記股東發出通知,宣布2024年度中期報告(「本次公司通訊文件」)的中、英文版本已可在公司及香港交易所披露易網站上獲得。非登記股東若需印刷版報告,可填妥申請表格並透過郵寄回公司。本公司提供了網上下載申請表格的選項,並設有熱線及電郵供股東查詢相關事宜。此通知僅針對股份存放於中央結算及交收系統(CCASS)的非登記股東,若股份已出售或轉讓,則無需理會此通知。
醫渡科技有限公司(「本公司」)已於2023年12月29日向非登記股東發出通知,宣布2024年度中期報告(「本次公司通訊文件」)的中、英文版本已可在公司及香港交易所披露易網站上獲得。非登記股東若需印刷版報告,可填妥申請表格並透過郵寄回公司。本公司提供了網上下載申請表格的選項,並設有熱線及電郵供股東查詢相關事宜。此通知僅針對股份存放於中央結算及交收系統(CCASS)的非登記股東,若股份已出售或轉讓,則無需理會此通知。
Medical Technology Limited (the “Company”) has issued a notice to non-registered shareholders on 29 December 2023 announcing that the Chinese and English versions of its 2024 Interim Report (the “Company Newsletter”) are available on the Company and the HKEX's disclosable websites. Non-registered shareholders may complete the application form and send it back to the company by mail if they require a printed report. The Company offers the option to download the application form online and has a hotline and email for shareholders' enquiries. This notice applies only to non-registered shareholders whose shares are stored in the Central Clearing and Settlement System (CCASS). If the shares have been sold or transferred, this notice is not required.
Medical Technology Limited (the “Company”) has issued a notice to non-registered shareholders on 29 December 2023 announcing that the Chinese and English versions of its 2024 Interim Report (the “Company Newsletter”) are available on the Company and the HKEX's disclosable websites. Non-registered shareholders may complete the application form and send it back to the company by mail if they require a printed report. The Company offers the option to download the application form online and has a hotline and email for shareholders' enquiries. This notice applies only to non-registered shareholders whose shares are stored in the Central Clearing and Settlement System (CCASS). If the shares have been sold or transferred, this notice is not required.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more